Abstract Details

Title Oral anticoagulation is a significant risk factor for spontaneous primary intraventricular hemorrhage

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) S29 - (-)

Poster/Presentation
Number 001

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Bhaskar Roy, MD, FAAN (Yale University) PRESENTER	Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Roy has stock in Cabaletta bio. . Dr. Roy has stock in Pfizer. Dr. Roy has stock in CAVA. The institution of Dr. Roy has received research support from Abcuro Pharmaceuticals. The institution of Dr. Roy has received research support from Immunovant. The institution of Dr. Roy has received research support from argenx.
Jussie Lima, MD (University of Connecticut, Hartford Hospital)	No disclosure on file
	No disclosure on file
	No disclosure on file
Nora S. Lee, MD	No disclosure on file

��ɫ����